Longitudinal proteomic profiling of over 1,800 patients revealed two distinct profiles of blood biomarkers measured on admission to hospital for COVID-19, which predict cognitive deficits 6 and 12 months later.
- Maxime Taquet
- Zuzanna Skorniewska
- Paul J. Harrison